Two Pompe Disease Treatments Are in Short Supply Weeks After Regulators Cited the Plant That Releases Them

Sanofi is facing supply shortfalls of two Pompe disease enzyme therapies following manufacturing and quality control problems at an Irish plant.

Have A Referral?